Blue Collar Vaccines and Therapeutics (BCVT) stands out for its profound commitment to advancing vaccine technology, developing novel therapeutics, and conducting both field trials and basic research. Drawing on decades of combined experience across military, academic, and industry settings, our team turns rigorous science into practical, real-world solutions.
Our Expertise
Vaccine Development
We have demonstrated expertise in vaccine development, especially utilizing Psoralen inactivation techniques for bacterial and viral pathogens. This includes culturing bacterial pathogens, inactivation and generation of pilot vaccine stock, animal work, and associated development and utilization of diagnostics for immunogenicity assays.
Therapeutics
Providing clinically relevant therapeutics and diagnostics, leveraging our decades of combined clinical experience. Members of BCVT bring a patient-focused approach to developing new therapeutic and diagnostic aids. Pairing state of the art pharmaceutics with new approaches in big data and machine learning, BCVT members have developed online calculators and created novel therapeutic approaches.
Clinical Trial Support
BCVT has an expansive experience in running Phase 1-3 trials. This includes designing, executing, and supporting Phase 1-2a trials along with randomized, placebo controlled Phase 3 trials across the world.
Preclinical and Basic Research
BCVT has experience in all phases of basic and preclinical research including the development of animal models, diagnostic assays. Leveraging our expansive contacts within academic laboratories, we have access to cutting edge molecular methods including next generation and whole genome sequencing, various “omic” techniques, and other approaches.